Squar Milner Financial Services’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-645
Closed -$9K 730
2018
Q3
$9K Hold
645
0.01% 509
2018
Q2
$8K Buy
+645
New +$8K 0.01% 628